Latest News about KYMR
Recent news which mentions KYMR
Insights Ahead: Kymera Therapeutics's Quarterly Earnings
October 30, 2024
Tickers
KYMR
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
September 09, 2024
Tickers
KYMR
From Benzinga
This BJ's Wholesale Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
August 26, 2024
From Benzinga
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
July 14, 2024
From Benzinga
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 09, 2024
From Benzinga
From Benzinga
Tickers
KYMR
From InvestorPlace
Piper Sandler Maintains Overweight Rating for Kymera Therapeutics: Here's What You Need To Know
February 27, 2024
Tickers
KYMR
From Benzinga
Breaking Down Kymera Therapeutics: 4 Analysts Share Their Views
February 23, 2024
Tickers
KYMR
From Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
From Benzinga
More Than $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
November 07, 2023
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for Kymera Therapeutics: Here's What You Need To Know
November 03, 2023
Tickers
KYMR
From Benzinga
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 06, 2023
From Benzinga
Why Shares of Kymera Therapeutics Jumped on Tuesday
October 03, 2023
From Motley Fool
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.